Tumour budding: a promising parameter in colorectal cancer.
about
Tumor Budding: The Name is EMT. Partial EMTPrognostic stratification of colorectal cancer patients: current perspectivesThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careActin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tractBowel cancer screening-generated diagnostic conundrum of the century: pseudoinvasion in sigmoid colonic polypsMolecular and pathogenetic aspects of tumor budding in colorectal cancerQuantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancerTropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancerControversies in the pathological assessment of colorectal cancerRole of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.Histopathological features predict metastatic potential in locally advanced colon carcinomasHigh tumor budding stratifies breast cancer with metastatic properties.Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinomaTumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic ToolThe relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancerMicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?Tumour budding with and without admixed inflammation: two different sides of the same coin?Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome.Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer.Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition.Tumour budding in head and neck squamous cell carcinoma - a systematic review.Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.Prognostic value of tumour budding in oesophageal cancer: a meta-analysis.Tumour budding in colorectal cancer: what do we know and what can we do?Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma.Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patientsDetailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting.The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin.Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma.Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancerRecommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
P2860
Q26748136-F066C44D-E604-4312-9D64-203DE9C43853Q26823543-EFE64808-6360-42F5-8482-77D5C1C6ACEFQ28066460-7CBF7A2E-6CA2-4839-834D-F0EF4272011FQ28082719-23A98609-9868-430D-B05F-B78775604AFBQ28084175-FDB5A66C-B811-4324-BE30-3E9FAF553966Q28085313-F57F5C8B-4DD7-45DA-9DDF-9774179D8D4EQ30583738-8AE21C2B-8969-4167-A001-B32AC42A7299Q33750123-393A4B80-9612-4CB7-95A0-4D92D0191942Q34008807-4E2B2757-C143-4069-8C4D-6E6634EA9AB3Q34442342-24615502-3992-4848-BFBF-425C86F96659Q35016109-6B4573C0-EB59-43D7-ACED-B2168477EE78Q35203546-04FBC63D-726C-428E-BD63-D105019B66A3Q35713627-5440A341-BEF5-4215-82B1-EE33C4CCEC93Q35877252-82FD9B09-F584-4189-B8CD-5D4EA77B7A08Q36054317-59944391-6269-4DAC-ADE7-2F79933450EBQ36203396-C14411E6-7B17-41BD-815F-144D84169BA1Q36249513-8301BE4F-40D5-4945-A6D6-C60FF884788AQ36295024-1E6577A8-D132-44EF-8631-CBDC5EF26BA8Q36382688-95A7F0C4-45F8-4685-B10E-85425E7E59E9Q36450516-F2D052E5-098B-4775-AEC1-10B8F805792FQ36750548-1351D32F-BE7A-4798-A691-83F010F1E59CQ36821128-C0D5D1E6-F6E0-4D5B-AACC-79F8BB805214Q38073775-6F124F2C-BE6B-4B3C-968A-403F8653A5CFQ38142723-CEC88D79-8A8F-42A0-84FF-ACC050BAD18CQ38174869-37EC842E-A589-4FF9-AFDB-BD9EE1449A72Q38217654-15109D5F-B2AB-4332-9708-D11ACEF5610EQ38241953-1B492846-F034-429D-BC23-D81D305A73E5Q38548753-A902BAE3-5FDA-4A33-8C94-FCE77EC8BF53Q38650462-A2E97A56-44FF-4162-816C-FD512A60D18EQ38973613-DFEEC594-F723-454B-9C54-7A5F58733AB3Q38979960-A09A4C74-D202-4A04-94A1-42EA623EC808Q39021801-215241B0-C470-4CAC-827B-5F51F4EAEB65Q39023133-301750D0-4378-4B2E-89DB-D7730775B26CQ39670929-99AA30C9-C44B-4216-8981-F7EDCC5A99D3Q39684656-D801A574-8345-4D37-B399-5A2E47DA1A9FQ40258500-82F656BF-24B4-4382-A839-0EF8F66A644AQ41484734-8EF44426-76B5-4D9E-AF3F-985B2675BCEBQ41608514-F836A4C8-A774-44D5-81E8-674F4B98EA15Q42234716-EB9C2A7C-7A9E-43BE-95D8-28453C843A97Q46067914-0070BD49-C0B4-4188-8F2F-3C8F3C13C881
P2860
Tumour budding: a promising parameter in colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumour budding: a promising parameter in colorectal cancer.
@en
type
label
Tumour budding: a promising parameter in colorectal cancer.
@en
prefLabel
Tumour budding: a promising parameter in colorectal cancer.
@en
P2093
P2860
P356
P1476
Tumour budding: a promising parameter in colorectal cancer.
@en
P2093
E Karamitopoulou
P2860
P2888
P304
P356
10.1038/BJC.2012.127
P407
P577
2012-04-24T00:00:00Z
2012-05-22T00:00:00Z
P5875
P6179
1028388342